Bryan DeBoer

Business news, market intelligence, and global industry analysis.

The Latest

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

What Lithia & Driveway’s latest dealership acquisitions reveal about the future of car retail

Lithia & Driveway expands its U.S. dealership network with Tennessee and Oregon acquisitions. Discover what the move signals for auto retail consolidation.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

March 4, 2026